{"id":769953,"date":"2026-06-30T00:29:10","date_gmt":"2026-06-30T00:29:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/769953\/"},"modified":"2026-06-30T00:29:10","modified_gmt":"2026-06-30T00:29:10","slug":"canada-approves-first-generic-semaglutide-injection-for-weight-loss","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/769953\/","title":{"rendered":"Canada approves first generic semaglutide injection for weight loss"},"content":{"rendered":"

<\/a> FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo\/Amanda Andrade-Rhoades, File) – The Canadian Press <\/p>\n

OTTAWA \u2014 Health Canada has approved the first generic semaglutide injection for weight loss. <\/p>\n

The product from the Canadian company Apotex is known as Svemia and is a generic version of the brand-name drug Wegovy from Denmark’s Novo Nordisk. <\/p>\n

Health Canada says Svemia is for the once-weekly treatment of people 12 and over, as a supplement to a reduced-calorie diet and increased physical activity for chronic weight management. <\/p>\n

It’s the third generic semaglutide product approved by the department, though the first two were authorized for the treatment of Type 2 diabetes in adults. <\/p>\n

Generic versions of Novo Nordisk’s Ozempic by India-based Dr. Reddy’s Laboratories and Apotex were approved earlier this year. <\/p>\n

Health Canada says it’s reviewing six other submissions for generic semaglutide from different companies and expects to make more decisions in the coming weeks and months. <\/p>\n

This report by The Canadian Press was first published June 29, 2026. <\/p>\n

The Canadian Press <\/p>\n","protected":false},"excerpt":{"rendered":"FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo\/Amanda Andrade-Rhoades, File) –…\n","protected":false},"author":2,"featured_media":769954,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[250508,49,48,273406,251089,12537,44,5246,944,13667,11988],"class_list":["post-769953","post","type-post","status-publish","format-standard","has-post-thumbnail","category-canada","tag-apotex","tag-ca","tag-canada","tag-dr-reddy39s-laboratories","tag-generic-version","tag-health-canada","tag-news","tag-novo-nordisk","tag-the-canadian-press","tag-wegovy","tag-weight-management"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/769953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=769953"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/769953\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/769954"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=769953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=769953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=769953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}